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Neuroadaptations of neuronal ensembles in the mesocorticolimbic reward system mediate memory 
processes, which link drug-seeking experiences to the contexts in which they occur (1–3). In many 
individuals with alcohol or drug-related problems, such memory processes imbue drug-related 
contexts with motivational salience – a resonant incentive motivational attribution attached to drug-
predictive cues, which drives addictive behaviors (4–6). When such memories are recalled, they are 
thought to return to a volatile state in which they could be altered before undergoing reconsolidation 
for future use (7–9). A recent notable study sheds light on a condition by which to block memory 
reconsolidation and subsequent responsivity to alcohol-related stimuli in individuals with alcohol-
related problems (10).
In hazardous drinkers, Das et al. (10) destabilized alcohol-related memory reconsolidation through 
a procedure which maximized omission prediction error (PE) through explicitly guided expectancy 
violation during memory retrieval (10). PE involved these drinkers being led to believe that they 
will be able to drink alcohol through presentation of alcohol conditioned stimuli to reactivate their 
alcohol-related memories and explicit instructions designed to maximize the expectation of alcohol 
reward but then were unexpectedly prevented from drinking. Ten minutes later, alcohol-specific cues 
were paired with disgusting tastes and images in a counter-conditioning procedure designed to rewrite 
the alcohol-related memory. Hazardous drinkers exhibited reduced attentional bias to and liking of 
alcohol-related stimuli and a reduced positive expectancy of alcohol 1 week following this PE and 
counter-conditioning procedure. Interestingly, this memory reactivation-dependent reduction in 
the motivational salience and valuation of alcohol-related stimuli generalized to novel alcohol cues. 
Two comparison groups of hazardous drinkers were included – one that did not undergo PE upon 
alcohol-related memory retrieval and one in which the alcohol-related memory was not retrieved. 
Neither of these comparison groups exhibited this reduction in motivational salience or valuation 
of alcohol-related stimuli, relative to neutral stimuli. This study suggests an innovative approach 
to destabilize retrieval of alcohol-related memories using a PE manipulation paired with counter 
conditioning. This method could be useful to disrupt or weaken maladaptive alcohol memories in 
clinical practice if future research shows it to be a selective alcohol memory-rewriting intervention.
Further research should identify the necessary and sufficient parameters for producing durable 
weakening of alcohol- and drug-related memories by fortifying PE-induced memory destabilization, 
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together with medication-assisted therapy (MAT) and counter 
conditioning. A fuller insight gleaned from understanding 
what is required for memory reconsolidation to be blocked in 
a long-lasting manner should aid development of treatments 
to disrupt memories associated with substance use disorders 
(SUDs). First, it would be helpful for research to test how efficacy 
of PE-based strategies to block memory reconsolidation could be 
enhanced by pharmacological adjuncts, for example, adrenergic 
beta-receptor blockers or adrenergic alpha-2 receptor agonists, 
which prior research suggests could be useful aids to impair 
memory reconsolidation (11, 12). Second, research is needed 
to identify the parameters necessary to optimize the efficacy of 
counter conditioning and to extend the applicability of the Das 
et  al. (10) memory-destabilization approach to treating other 
SUDs. Further research should also identify how to maximize the 
generalizability of memory alteration to other drug-predictive 
contexts, in order to generalize this relearning across various 
drug-related surroundings.
Individuals with multiple SUDs may require more intense 
care to augment any beneficial effects of rewriting maladaptive 
alcohol- or drug-related memories. Thus, precision medicine 
research also needs to be conducted to establish effectiveness 
of stepped care, tailored treatment approaches using nuanced 
clinical decision support (CDS) tools, and shared decision-
making approaches to move SUDs patients into more intensive 
interventions, which attend to their personalized phenotypes 
that present obstacles to their recovery and overall wellness, 
their risk concerns, and preferences. Research is also needed 
on how to optimize shared decision making between patients 
and providers to tailor personalized medical care to particular 
problems and risk categories which individual patients report 
as most distressing to their functioning in daily lives. Thus, 
ultimately, precision medicine research will also need to assess 
the effectiveness of patient-centered care approaches utilizing 
shared decision making to treating substance use problems and 
co-occurring behavioral health issues, considering individual 
preferences for treatment options, taking into account: for 
instance, (a) SUD severity, (b) readiness of patients to change 
their harmful substance use, (c) underlying reasons for readiness 
or hesitancy to do so, (d) presence of co-occurring psychiatric 
and other medical conditions, and (e) how to help patients in 
instituting a patient-centered treatment plan consistent with 
their co-occurring conditions, readiness to change, and their 
preferences/values (13, 14).
Clinical research programs with practice-based research 
networks serving patient populations with substance use prob-
lems can play an important role in this endeavor. Existing health 
information system infrastructures in practice-based research 
networks should be leveraged to help accelerate this line of 
research, which, in turn, could lead to more efficient enrollment 
of patients into trials, accelerated recruitment of providers to 
deliver study interventions, and more efficient use of existing 
health information technologies such as electronic health record 
systems (EHRs) (13, 14).
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